Predictive value of 2-deoxy-2-fluorine-18-fluoro-D-glucose positron emission tomography/computed tomography parameters for MYCN amplification in high-risk neuroblastoma
Description
CONCLUSION: SUV(peak) can predict the MYCN amplification in HR-NB patients. The predictive model constructed by combining SUV(peak) and age can distinguish MYCN status in HR-NB non-invasively with superior efficacy compared to using SUV(peak) alone.
